文献速递冠心病外科

双侧胸廓内动脉搭桥在糖尿病患者中应用的时代是否已到来?一项更新荟萃分析

Is the era of bilateral internal thoracic artery grafting coming for diabetic patients? An updated meta-analysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-02-23

该荟萃分析纳入1项随机对照试验和17项观察性研究,共129,871例糖尿病患者,比较单侧与双侧胸廓内动脉搭桥的安全性和疗效。结果显示双侧组深部胸骨伤口感染总体发生率较高(3.26% vs 1.70%),但采用骨骼化获取技术时两组无显著差异;两组院内死亡率相当(2.80% vs 2.36%);双侧组长期全因死亡和心源性死亡风险更低。

要点

  • 双侧胸廓内动脉搭桥在糖尿病患者中与更好的长期生存相关
  • 骨骼化获取技术下深部胸骨伤口感染风险未见显著增加
  • 院内死亡率两组相当,但双侧组总体深部胸骨伤口感染率较高

核心结论

  • 与单侧胸廓内动脉搭桥相比,双侧胸廓内动脉搭桥与糖尿病患者长期生存改善相关。
  • 骨骼化获取双侧胸廓内动脉不增加深部胸骨伤口感染风险。
  • 因此,应鼓励外科医生在糖尿病患者中更常规地采用骨骼化双侧胸廓内动脉搭桥。

研究设计与样本

  • 研究类型为荟萃分析,纳入前瞻性随机试验或观察性研究。
  • 检索了PubMed、Cochrane Library、Embase和ISI Web of Knowledge四个电子数据库。
  • 共纳入1项随机对照试验和17项观察性研究,总计129,871例糖尿病患者,其中单侧胸廓内动脉组124,233例,双侧组5,638例。

主要发现

  • 双侧组深部胸骨伤口感染总体发生率为3.26%,单侧组为1.70%,双侧组显著更高。
  • 采用骨骼化获取技术时,两组深部胸骨伤口感染风险无显著差异。
  • 院内死亡率双侧组为2.80%,单侧组为2.36%,两组相当。
  • 双侧组长期全因死亡风险更低(风险比1.41;95%置信区间1.18-1.67;P < .001;I2 = 63%)。
  • 双侧组心源性死亡风险更低(风险比3.15;95%置信区间2.23-4.46;P < .001;I2 = 0%)。

临床怎么用

  • 在糖尿病患者中可考虑采用骨骼化技术获取双侧胸廓内动脉进行搭桥,以降低深部胸骨伤口感染风险。
  • 双侧胸廓内动脉搭桥可能为糖尿病患者带来长期生存获益,但需权衡伤口并发症风险。

局限性

  • 纳入研究以观察性研究为主,仅1项随机对照试验,可能存在选择偏倚和混杂因素。
  • 长期死亡风险分析异质性较高(全因死亡I2 = 63%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Because of an increased risk of sternal wound complications, the use of bilateral internal thoracic artery grafting in diabetic patients remains controversial. The objective of the present meta-analysis is to compare the safety and efficacy of single internal thoracic artery and bilateral internal thoracic artery grafting in the diabetic population. METHODS: Four electronic databases, including PubMed, the Cochrane Library, Embase, and ISI Web of Knowledge, were comprehensively searched. Prospective randomized trials or observational studies comparing single internal thoracic artery and bilateral internal thoracic artery were considered eligible for the current study. RESULTS: A literature search yielded 1 randomized controlled trial and 17 observational studies (129,871 diabetic patients: 124,233 single internal thoracic arteries and 5638 bilateral internal thoracic arteries). Pooled analysis demonstrated overall incidence of deep sternal wound infection in the bilateral internal thoracic artery grafting group was significantly higher than in the single internal thoracic artery grafting group (3.26% for bilateral internal thoracic artery vs 1.70% for single internal thoracic artery). No significant difference was found between both groups in terms of risk of deep sternal wound infection when the skeletonized harvesting technique was adopted. Furthermore, in-hospital mortality was comparable between both groups (2.80% for bilateral internal thoracic artery vs 2.36% for single internal thoracic artery). However, compared with single internal thoracic artery grafting, bilateral internal thoracic artery grafting could confer a lower risk for long-term overall mortality (hazard ratio, 1.41; 95% confidence interval, 1.18-1.67; P < .001; I2 = 63%) and cardiac mortality (hazard ratio, 3.15; 95% confidence interval, 2.23-4.46; P < .001; I2 = 0%). CONCLUSIONS: Compared with single internal thoracic artery grafting, bilateral internal thoracic artery grafting is associated with enhanced long-term survival among diabetic patients. Skeletonization of bilateral internal thoracic artery is not associated with an increased risk of deep sternal wound infection. Therefore, surgeons should be encouraged to adopt bilateral internal thoracic artery grafting in a skeletonized manner more routinely in diabetic patients.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Zhou P, Zhu P, Nie Z, et al. Is the era of bilateral internal thoracic artery grafting coming for diabetic patients? An updated meta-analysis. J Thorac Cardiovasc Surg. 2019. PMID: 30952540. doi:10.1016/j.jtcvs.2019.01.129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。